Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.
Adebahr S, Collette S, Shash E, Lambrecht M, Le Pechoux C, Faivre-Finn C, De Ruysscher D, Peulen H, Belderbos J, Dziadziuszko R, Fink C, Guckenberger M, Hurkmans C, Nestle U. Adebahr S, et al. Among authors: de ruysscher d. Br J Radiol. 2015 Jul;88(1051):20150036. doi: 10.1259/bjr.20150036. Epub 2015 Apr 15. Br J Radiol. 2015. PMID: 25873481 Free PMC article. Clinical Trial.
Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study.
De Ruysscher D, Wanders S, Minken A, Lumens A, Schiffelers J, Stultiens C, Halders S, Boersma L, Baardwijk Av, Verschueren T, Hochstenbag M, Snoep G, Wouters B, Nijsten S, Bentzen SM, Kroonenburgh Mv, Ollers M, Lambin P. De Ruysscher D, et al. Radiother Oncol. 2005 Oct;77(1):5-10. doi: 10.1016/j.radonc.2005.06.014. Epub 2005 Jul 12. Radiother Oncol. 2005. PMID: 16019093 Clinical Trial.
Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients.
van Baardwijk A, Bosmans G, Dekker A, van Kroonenburgh M, Boersma L, Wanders S, Ollers M, Houben R, Minken A, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: de ruysscher d. Radiother Oncol. 2007 Feb;82(2):145-52. doi: 10.1016/j.radonc.2007.01.007. Epub 2007 Jan 26. Radiother Oncol. 2007. PMID: 17258339
Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study.
De Ruysscher D, Houben A, Aerts HJ, Dehing C, Wanders R, Ollers M, Dingemans AM, Hochstenbag M, Boersma L, Borger J, Dekker A, Lambin P. De Ruysscher D, et al. Radiother Oncol. 2009 Jun;91(3):415-20. doi: 10.1016/j.radonc.2009.01.004. Epub 2009 Feb 3. Radiother Oncol. 2009. PMID: 19195730
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.
Aerts HJ, van Baardwijk AA, Petit SF, Offermann C, Loon Jv, Houben R, Dingemans AM, Wanders R, Boersma L, Borger J, Bootsma G, Geraedts W, Pitz C, Simons J, Wouters BG, Oellers M, Lambin P, Bosmans G, Dekker AL, De Ruysscher D. Aerts HJ, et al. Among authors: de ruysscher d. Radiother Oncol. 2009 Jun;91(3):386-92. doi: 10.1016/j.radonc.2009.03.006. Epub 2009 Mar 28. Radiother Oncol. 2009. PMID: 19329207 Free PMC article.
Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.
Spoelstra FO, Senan S, Le Péchoux C, Ishikura S, Casas F, Ball D, Price A, De Ruysscher D, van Sörnsen de Koste JR; Lung Adjuvant Radiotherapy Trial Investigators Group. Spoelstra FO, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1106-13. doi: 10.1016/j.ijrobp.2009.02.072. Epub 2009 Jun 27. Int J Radiat Oncol Biol Phys. 2010. PMID: 19560881
491 results